Hi-PCR® COVID FLU RSV Multiplex Probe PCR Kit

The coronavirus disease 2019 (COVID‐19) pandemic is an ongoing global health crisis caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The COVID‐19 pandemic began in December 2019 in Wuhan City, China. Clinical presentation of COVID‐19 ranged from asymptomatic cases and mild illness to critical conditions featuring acute respiratory distress syndrome. Influenza virus (Flu) and respiratory syncytial virus (RSV) are common respiratory pathogens that cause seasonal epidemics. Influenza infection tends to be less severe, typically resulting in uncomplicated upper respiratory tract illness, but, in rare cases, influenza infection can induce a complicated disease with severe viral pneumonia. RSV is recognized as the most common cause of bronchiolitis and pneumonia in children younger than 1 year. RSV infection can produce common cold‐like symptoms but may be severe in infants and young children. The clinical presentations of SARS‐CoV‐2, influenza, and RSV infections have overlapping symptoms, thus differential diagnosis of these diseases is challenging. Rapid diagnosis is needed in elderly patients because SARS‐CoV‐2, influenza, and RSV infections result in substantial morbidity and mortality specifically in these patients. In the COVID‐19 pandemic era, clinicians may encounter a co‐infection of SARS‐CoV‐2 with influenza or RSV. Therefore, multiplex detection of SARS‐CoV‐2, Influenza, and RSV will be very essential. HiMedia has developed a Multiplex Reverse Transcriptase Real‐Time PCR kit which enables the clinicians and public health laboratories to quickly diagnose and differentiate SARS‐CoV‐2, Influenza and RSV infections infection in a two‐tube reaction. NOTE: Hi‐PCR® COVID FLU RSV Multiplex Probe PCR Kit is for in‐vitro use only.

Hi‐PCR® COVID FLU RSV Multiplex Probe PCR Kit is a TaqMan based chemistry. It is intended for use by qualified clinical laboratory personnel trained in the techniques of real‐time PCR and in vitro diagnostic procedures. The kit is recommended for sensitive and specific detection of SARS‐CoV‐2, influenza and RSV infections in clinical samples.

Hi‐PCR® COVID FLU RSV Multiplex Probe PCR Kit includes two sets of primer‐probe mix specific to detect SARS‐CoV‐2 virus, influenza A virus (swine flu H1N1 & H3N2, separately), influenza B virus and RSV infections. In addition, both the tubes contain an internal control (IC) gene to identify RNA extraction efficiency and to ensure successful PCR reaction. The kit also provides positive controls for validity of the test.